Wockhardt Limited — Colchicine Exporter Profile

Geopolitical & Trade Policy Impact on Wockhardt Limited's Colchicine Exports

Wockhardt's export operations are influenced by various geopolitical factors. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased shipping costs and extended transit times for Indian pharmaceutical exporters. These disruptions pose challenges for time-sensitive products, particularly those requiring stringent cold-chain logistics. (pharmaceuticalcommerce.com)

In the U.S., recent tariff policies have introduced additional complexities. In August 2025, the U.S. imposed broad tariffs on imports from over 60 countries, including India, with rates reaching up to 39%. These tariffs have impacted nearly 55% of India's exports to the U.S., placing Indian pharmaceutical companies at a competitive disadvantage. (apnews.com)

Conversely, the U.S.-China trade tensions have created opportunities for Indian pharmaceutical companies to fill supply gaps in the American market. However, the overall impact of U.S. tariff policies remains a significant concern for exporters like Wockhardt.

In the European Union, compliance with the Falsified Medicines Directive (FMD) has become increasingly stringent. Indian exporters must invest in advanced serialization and traceability systems to meet these requirements, ensuring the authenticity and safety of pharmaceutical products in the EU market.